Ebolaviruses are among the most dangerous viruses known to affect humans. Three different species have caused large outbreaks in Africa. The most common is the Zaire ebolavirus, which has specific vaccines and treatments available. However, a different species called Bundibugyo ebolavirus currently has no approved vaccines or therapies. This species is responsible for an ongoing outbreak in the Democratic Republic of the Congo and Uganda. It is the largest recorded Bundibugyo outbreak so far. The lack of specific countermeasures makes it harder for health workers to control the spread. Scientists are now studying whether a licensed vaccine developed for the Zaire strain might offer at least partial protection against the Bundibugyo virus. If proven effective, this could help slow the outbreak and save lives. Research is ongoing to confirm the level of protection. Meanwhile, health officials continue to monitor the situation and implement containment measures. The outbreak underscores the need for broader vaccine development against all ebolavirus species.